Medical treatment of ascites in cirrhosis

Episode von Medizin - Open Access LMU - Teil 10/22 von Ludwig-Maximilians-Universität München · 1. Januar 1993

Medical treatment of cirrhotic ascites is essentially supportive, dictated by the patient's discomfort, impaired cardiovascular or respiratory function and potential for infection. Treatment of ‘simple’ ascites (moderate fluid accumulation, serum albumin > 3.5 g/dl, serum creatinine < 1.5 mg/dl, no electrolyte disturbance) is implemented sequentially. Only 10% of patients respond to dietary sodium restriction and bed rest; most require pharmacotherapy consisting of spironolactone, which increases the proportion of responding patients to 65% and loop diuretics, which may produce clinical improvement in an additional 20% (85% in all); in the remaining 15% of refractory patients, use of novel adjunctive therapies may be attempted. Patients with tense ascites, impaired renal function and electrolyte disturbances merit special consideration before diuretics are introduced. Spironolactone has long been a standard for the treatment of cirrhotic ascites because it directly antagonizes aldosterone. The loop diuretic most frequently added to spironolactone has been furosemide. However, there is preliminary evidence that torasemide may be more effective in some patients. Other investigational agents that may play a role in treatment of patients resistant to conventional drugs include ornipressin (a vasopressin analogue) and atrial natriuretic factor.

Weitere Episoden von „Medizin - Open Access LMU - Teil 10/22“

• A Survey of the Czechoslovak Follow-up of Lung Cancer Mortality in Uranium Miners 1. Januar 1993
• Alloreactive cytotoxic T lymphocytes generated in the presence of viral- derived peptides show exquisite peptide and MHC specificity 1. Januar 1993
• Application of Pulsed Field Gel Electrophoresis to Determine γ-ray-induced Double-strand Breaks in Yeast Chromosomal Molecules 1. Januar 1993
• Baculovirus-Mediated Expression of Human 65 kDa and 67 kDa Glutamic Acid Decarboxylases in SF9 Insect Cells and Their Relevance in Diagnosis of Insulin-Dependent Diabetes Mellitus 1. Januar 1993
• Concerted action of human chorionic gonadotropin and norepinephrine on intracellular-free calcium in human granulosa-lutein cells 1. Januar 1993
• Criteria of applicability for autoradiography of tritium 1. Januar 1993
• Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome 1. Januar 1993
• Disinhibition of hippocampal CA3 neurons induced by suppression of an adenosine A1 receptor-mediated inhibitory tonus: Pre- and postsynaptic components 1. Januar 1993
• Effect of oxytocin on free intracellular Ca2+ levels and progesterone release by human granulosa-lutein cells 1. Januar 1993
• Effect of phospholipids and bile acids on cholesterol nucleation time and vesicular/micellar cholesterol in gallbladder bile of patients with cholesterol stones 1. Januar 1993
• Functional characterization of the catalytic site of the tetanus toxin light chain using permeabilized adrenal chromaffin cells 1. Januar 1993
• Genomic Organization, Splice Variants and Expression of CGMl, a CD66-related Member of the Carcinoembryonic Antigen Gene Family 1. Januar 1993
• Glucocorticoids rapidly inhibit oxytocin-stimulated adrenocorticotropin release from rat anterior pituitary cells, without modifying intracellular calcium transients 1. Januar 1993
• Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies 1. Januar 1993
• Indomethacin decreases viscosity of gallbladder bile in patients with cholesterol gallstone disease 1. Januar 1993

Alle Episoden von Medizin - Open Access LMU - Teil 10/22 · Mehr Bildung-Podcasts